Ignite Creation Date:
2024-05-06 @ 7:00 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05853835
Status:
RECRUITING
Last Update Posted:
2024-06-11
First Post:
2023-04-28
Brief Title:
First-in-Human Trial in Healthy Adult Volunteers to Evaluate Safety Tolerability and PK of LAPIX Study Drug LPX-TI641
Sponsor:
LAPIX Therapeutics Inc
Organization:
LAPIX Therapeutics Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Multiple Sclerosis |
| Autoimmune Diseases |
Keywords: